Select Medical Holdings Stock EBITDA
| SEM Stock | USD 18.65 0.10 0.53% |
Select Medical Holdings fundamentals help investors to digest information that contributes to Select Medical's financial success or failures. It also enables traders to predict the movement of Select Stock. The fundamental analysis module provides a way to measure Select Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Select Medical stock.
Select |
Select Medical Holdings Company EBITDA Analysis
Select Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Select Medical EBITDA | 789.74 M |
Most of Select Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Select Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Select Medical Holdings reported earnings before interest,tax, depreciation and amortization of 789.74 M. This is 9.99% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 79.74% higher than that of the company.
Select EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Select Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Select Medical could also be used in its relative valuation, which is a method of valuing Select Medical by comparing valuation metrics of similar companies.Select Medical is currently under evaluation in ebitda category among its peers.
Select Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0484 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 6.78 B | ||||
| Shares Outstanding | 128.99 M | ||||
| Shares Owned By Insiders | 14.59 % | ||||
| Shares Owned By Institutions | 83.62 % | ||||
| Number Of Shares Shorted | 3.59 M | ||||
| Price To Earning | 13.33 X | ||||
| Price To Book | 1.26 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 6.66 B | ||||
| Gross Profit | 1.4 B | ||||
| EBITDA | 789.74 M | ||||
| Net Income | 299.73 M | ||||
| Cash And Equivalents | 97.91 M | ||||
| Cash Per Share | 1.35 X | ||||
| Total Debt | 4.96 B | ||||
| Debt To Equity | 3.68 % | ||||
| Current Ratio | 1.02 X | ||||
| Book Value Per Share | 14.79 X | ||||
| Cash Flow From Operations | 582.06 M | ||||
| Short Ratio | 4.38 X | ||||
| Earnings Per Share | 2.14 X | ||||
| Price To Earnings To Growth | 1.37 X | ||||
| Target Price | 29.5 | ||||
| Number Of Employees | 38.4 K | ||||
| Beta | 1.29 | ||||
| Market Capitalization | 2.41 B | ||||
| Total Asset | 7.69 B | ||||
| Retained Earnings | 751.86 M | ||||
| Working Capital | 9.18 M | ||||
| Current Asset | 749.15 M | ||||
| Current Liabilities | 729.28 M | ||||
| Annual Yield | 0.03 % | ||||
| Net Asset | 7.69 B | ||||
| Last Dividend Paid | 0.5 |
About Select Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Select Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Select Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Select Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Select Medical Piotroski F Score and Select Medical Altman Z Score analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.